Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2026)
Treace Medical Concepts (TMCI) posted Interest & Investment Income of $501000.0 for Q1 2026, down 4.93% on a QoQ basis from $527000.0 in Q4 2025, and down 40.43% year-over-year from $841000.0 in Q1 2025.
Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $501000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 40.43% year-over-year to $501000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 41.74% YoY) and the FY2025 annual result came in at $2.8 million, down 43.06% from the prior year.
- Interest & Investment Income was $501000.0 for Q1 2026 at Treace Medical Concepts, down from $527000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.0 million in Q2 2023 and bottomed at $9000.0 in Q1 2022.
- A 5-year average of $952588.2 and a median of $841000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 16333.33% — and 2024, when it plunged 47.4%.
- Treace Medical Concepts' Interest & Investment Income stood at $753000.0 in 2022, then jumped by 126.96% to $1.7 million in 2023, then tumbled by 47.4% to $899000.0 in 2024, then plunged by 41.38% to $527000.0 in 2025, then dropped by 4.93% to $501000.0 in 2026.
- Business Quant data shows TMCI's Interest & Investment Income at $501000.0 in Q1 2026, $527000.0 in Q4 2025, and $634000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Treace Medical Concepts | 262.89 Mn | 211.04 Mn | 37.41 Mn | 501,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 501,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 775,000.00 |
| Mar 31, 2025 | 841,000.00 |
| Dec 31, 2024 | 899,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 753,000.00 |
| Sep 30, 2022 | 420,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 6,000.00 |